Lv2
106 积分 2023-11-28 加入
Induction chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: a phase 3, multicentre, randomised controlled trial
23天前
已完结
Gemcitabine and Cisplatin Induction Chemotherapy in Nasopharyngeal Carcinoma
23天前
已完结
Hyperfractionation compared with standard fractionation in intensity-modulated radiotherapy for patients with locally advanced recurrent nasopharyngeal carcinoma: a multicentre, randomised, open-label, phase 3 trial
2个月前
已完结
Differences in the association of time to treatment initiation and survival according to various head and neck cancer sites in a nationwide cohort
3个月前
已完结
Incidence and Site‐Specific Risk Factors of Jaw Osteoradionecrosis for Head and Neck Patients in the IMRT / VMAT Era: Evidence From a Large, Hospital‐Based Cohort
3个月前
已完结
Xerostomia: An easily ignored symptom induced by induction chemotherapy in patients with nasopharyngeal carcinoma
3个月前
已完结
Prognostic Assessment and Risk Stratification of Laryngeal Spindle Cell Carcinoma: A Multicenter Retrospective Study
3个月前
已关闭
Laryngeal spindle cell carcinoma: A population-based analysis of incidence and survival
3个月前
已完结
Pembrolizumab with or without bevacizumab in platinum-resistant recurrent or metastatic nasopharyngeal carcinoma: a randomised, open-label, phase 2 trial
4个月前
已完结
Data from Phase II, Randomized Study of Spartalizumab (PDR001), an Anti–PD-1 Antibody, versus Chemotherapy in Patients with Recurrent/Metastatic Nasopharyngeal Cancer
4个月前
已关闭
皖公网安备34019202002308
